Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (31-40 of 194) with videos related to

Pageof 20
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|January 14, 2022
Current status and future outlooks on therapeutic drug monitoring of fluorouracilEduard Schmulenson, Nigina Zimmermann, Gerd Mikus, et al.
Drug Metabolism Reviews|June 20, 2019
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolismJosefine Schulz, Franziska Kluwe, Gerd Mikus, et al.
Clinical Pharmacokinetics|March 12, 2020
Drug-Drug Interactions with Direct Oral AnticoagulantsKathrin I Foerster, Simon Hermann, Gerd Mikus, et al.
Annals of Hematology|April 17, 2014
Normal CYP3A activity during arsenic trioxide therapyNelly Siller, Gerlinde Egerer, Tilman Bochtler, et al.
Rapid Communications in Mass Spectrometry : RCM|July 20, 2007
Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasmaAnne-Kathrin Gehrig, Gerd Mikus, Walter E Haefeli, et al.
British Journal of Clinical Pharmacology|July 23, 2017
Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studiesAndreas D Meid, Sarah Mächler, Walter E Haefeli, et al.
European Journal of Clinical Pharmacology|February 20, 2008
Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trialsJob Harenberg, Ingrid Jörg, Yvonne Vukojevic, et al.
Clinical Pharmacokinetics|October 30, 2020
Correction to: Drug-Drug Interactions with Direct Oral AnticoagulantsKathrin I Foerster, Simon Hermann, Gerd Mikus, et al.
Pharmaceutical Research|September 28, 2022
Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxideJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Pharmaceutical Research|October 22, 2022
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in HumansJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Pageof 20

Showing results (31-40 of 194) with videos related to

Sort By:
Pageof 20
Expert Opinion on Drug Metabolism & Toxicology|January 14, 2022
Current status and future outlooks on therapeutic drug monitoring of fluorouracilEduard Schmulenson, Nigina Zimmermann, Gerd Mikus, et al.
Drug Metabolism Reviews|June 20, 2019
Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolismJosefine Schulz, Franziska Kluwe, Gerd Mikus, et al.
Clinical Pharmacokinetics|March 12, 2020
Drug-Drug Interactions with Direct Oral AnticoagulantsKathrin I Foerster, Simon Hermann, Gerd Mikus, et al.
Annals of Hematology|April 17, 2014
Normal CYP3A activity during arsenic trioxide therapyNelly Siller, Gerlinde Egerer, Tilman Bochtler, et al.
Rapid Communications in Mass Spectrometry : RCM|July 20, 2007
Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasmaAnne-Kathrin Gehrig, Gerd Mikus, Walter E Haefeli, et al.
British Journal of Clinical Pharmacology|July 23, 2017
Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studiesAndreas D Meid, Sarah Mächler, Walter E Haefeli, et al.
European Journal of Clinical Pharmacology|February 20, 2008
Anticoagulant effects of idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trialsJob Harenberg, Ingrid Jörg, Yvonne Vukojevic, et al.
Clinical Pharmacokinetics|October 30, 2020
Correction to: Drug-Drug Interactions with Direct Oral AnticoagulantsKathrin I Foerster, Simon Hermann, Gerd Mikus, et al.
Pharmaceutical Research|September 28, 2022
Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxideJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Pharmaceutical Research|October 22, 2022
Microdialysis of Voriconazole and its N-Oxide Metabolite: Amalgamating Knowledge of Distribution and Metabolism Processes in HumansJosefine Schulz, Robin Michelet, Markus Zeitlinger, et al.
Pageof 20